Trademark: 86973934
Status Date
Monday, November 25, 2019
Filing Date
Wednesday, April 13, 2016
Published for Opposition
Tuesday, August 30, 2016
Abandoned Date
Monday, November 25, 2019
5 Human pharmaceuticals for the prevention or treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases and respiratory diseases; vaccines
Nov 25, 2019
Abandonment Notice E-Mailed - No Use Statement Filed
Nov 25, 2019
Abandonment - No Use Statement Filed
Mar 26, 2019
Notice Of Approval Of Extension Request E-Mailed
Mar 25, 2019
Extension 5 Granted
Mar 19, 2019
Extension 5 Filed
Mar 25, 2019
Case Assigned To Intent To Use Paralegal
Mar 19, 2019
Teas Extension Received
Oct 3, 2018
Notice Of Approval Of Extension Request E-Mailed
Oct 1, 2018
Extension 4 Granted
Oct 1, 2018
Extension 4 Filed
Oct 1, 2018
Teas Extension Received
Apr 20, 2018
Notice Of Approval Of Extension Request E-Mailed
Apr 18, 2018
Extension 3 Granted
Apr 18, 2018
Extension 3 Filed
Apr 18, 2018
Teas Extension Received
Oct 5, 2017
Notice Of Approval Of Extension Request E-Mailed
Oct 3, 2017
Extension 2 Granted
Oct 3, 2017
Extension 2 Filed
Oct 3, 2017
Teas Extension Received
Mar 29, 2017
Notice Of Approval Of Extension Request E-Mailed
Mar 27, 2017
Extension 1 Granted
Mar 27, 2017
Extension 1 Filed
Mar 27, 2017
Teas Extension Received
Oct 25, 2016
Noa E-Mailed - Sou Required From Applicant
Aug 30, 2016
Official Gazette Publication Confirmation E-Mailed
Aug 30, 2016
Published For Opposition
Aug 10, 2016
Notification Of Notice Of Publication E-Mailed
Jul 22, 2016
Approved For Pub - Principal Register
Jul 21, 2016
Assigned To Examiner
Apr 18, 2016
New Application Office Supplied Data Entered In Tram
Apr 16, 2016
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
